Beste apotheek van Nederland

Kloner R A, Mitchell M, Emmick J T. Cardiovascular effects of
tadalafil. [Review] [12 refs]. Am J Cardiol 2003;92(9A):37M­
46M.
Kloner R A, Sadovsky R, Johnson E G et al. Efficacy of
tadalafil in the treatment of erectile dysfunction in hypertensive
men on concomitant thiazide diuretic therapy. Int J Impot Res
2005;17(5):450-454.
Kloner R A, Sadovsky R, Johnson E G et al. Efficacy of
tadalafil in the treatment of erectile dysfunction in hypertensive
men on concomitant thiazide diuretic therapy. Br J Urol
2006;175(4):1450
Knispel H H. Penile venous surgery in impotence: results in
highly selected cases. Urol Int 1991;47(3):144-148.
Knispel H H, Huland H. Influence of cause on choice of therapy
in 174 patients with erectile dysfunction. Br J Urol
1992;147(5):1274-1276.
Koksal M, Ozdemir H, Kargi S et al. The effects of sildenafil on
ocular blood flow. Acta Ophthalmol Scand 2005;83(3):355-359.
Kongkanand A, Opanuraks J, Tantiwongse K et al. Evaluating
dose regimens of apomorphine, an open-label study. Int J Impot
Res 2003;15(Suppl 2):10-12.
Kongkanand A, Ratana-Olarn K, Wuddhikarn S et al.
Evaluation of transurethal alprostadil for safety and efficacy in
men with erectile dysfunction. J Med Assoc Thai
2002;85(2):223-228.
Kramer-Levien D J. Papaverine--the medical implant. AUAA J
1987;7(4):13-Jun.
Kriston L, Harms A, Berner M M. A meta-regression analysis of
treatment effect modifiers in trials with flexible-dose oral
sildenafil for erectile dysfunction in broad-spectrum
populations. Int J Impot Res 2006;18(6):559-565.
Kromann-Andersen B. Intracavernosal pharmacotherapy with
injection pen. Lancet 1988;1(8575-6):54-59.
Kuba R, Pohanka M, Zakopcan J et al. Sexual dysfunctions and
blood hormonal profile in men with focal epilepsy. Epilepsia
2006;47(12):2135-2140.
Kunelius P, Lukkarinenl O. Intracavernous self-injection of
prostaglandin E1 in the treatment of erectile dysfunction. Int J
Impot Res 1999;11(1):21-24.
Kuzmarov I W, Ross D, Skamene A et al. A sexual tune-up
program as an adjunct to intracavernous pharmacotherapy. Can J
Hum Sex 1993;2(4):239-241.
Labbate Lawrence A, Grimes Jamie B, Hines Alan et al.
Bupropion treatment of serotonin reuptake antidepressantassociated
sexual dysfunction. Ann Clin Psychiatry
1997;9(4):241-245.
Lakin M M, Montague D K, VanderBrug Medendorp
S et al. Intracavernous injection therapy: Analysis of
results and complications. Br J Urol
1990;143(6):1138-1141.
Lal S, Kiely M E, Thavundayil J X et al. Effect of
bromocriptine in patients with apomorphineresponsive
erectile impotence: an open study. J
Psychiatry Neurosci 1991;16(5):262-266.
Lance R, Albo M, Costabile R A et al. Oral trazodone
as empirical therapy for erectile dysfunction: a
retrospective review. Urology 1995;46(1):117-120.
Lane B Z, Ausmundson S J, Butler R S et al. Use of a
visual analog scale to assess pain of injection with
intracavernous injection therapy. Br J Sex Med
2005;2(3):428-431.
Laties A, Sharlip I. Ocular safety in patients using
sildenafil citrate therapy for erectile dysfunction.
[Review] [81 refs]. Br J Sex Med 2006;3(1):12-27.
Laties A M, Zrenner E. Viagra (sildenafil citrate) and
ophthalmology. Progress in Retinal & Eye Research
2002;21(5):485-506.
Laties A M, Fraunfelder F T, Flach A J et al. Ocular
safety of Viagra, (sildenafil citrate). Trans Am
Ophthalmol Soc 1999;97(pp 115-128):-128.
Lawless C, Cree J. Oral medications in the
management of erectile dysfunction. [Review] [15
refs]. J Am Board Fam Pract 1998;11(4):307-314.
Lawless C, Force R W. Sildenafil for erectile
dysfunction. J Fam Pract 1998;47(2):97-98.
Lawrence I G, Price D E, Howlett T A et al.
Correcting impotence in the male dialysis patient:
experience with testosterone replacement and vacuum
tumescence therapy. Am J Kidney Dis
1998;31(2):313-319.
Le Bon O, Lion K, Verbanck P et al. Fluparoxan in
male erectile disorder: A case report. Yakubutsu
Seishin Kodo 1995;9(1):67-68.
Lea A P, Bryson H M, Balfour J A. Intracavernous
alprostadil. A review of its pharmacodynamic and
pharmacokinetic properties and therapeutic potential
in erectile dysfunction. [Review] [123 refs]. Drugs
Aging 1996;8(1):56-74.
Lee J, Pommerville P, Brock G et al. Physician-rated
patient preference and patient- and partner-rated
preference for tadalafil or sildenafil citrate: results
from the Canadian 'Treatment of Erectile Dysfunction'
observational study. BJU Int 2006;98(3):623-629.
D-172